3 Questions Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Stock Owners Need Answered

Addressing SGYP stock recent decline, Trulance sales trajectory, and short-term risks facing Synergy Pharmaceuticals Inc (NASDAQ:SGYP).

Posted in Biotech Hunter, Healthcare & Biotech, Members | Tagged , , , , , | 7 Comments

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Stock Outlook Improves Behind Trulance Catalysts & Recent Developments

SGYP stock may finally be a good buy after Synergy Pharmaceuticals offering, Linzess’ label change, and smart recruiting from Valeant Pharmaceuticals

Posted in Biotech Hunter, Healthcare & Biotech, Members | Tagged , , , , , , , | 6 Comments

Is Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Stock A Buy After 15% Loss?

SGYP stock fell nearly 15% after Synergy Pharmaceuticals announced a larger offering at a lower price than expected. However, that’s not the biggest concern

Posted in Healthcare & Biotech, Members, Timely Analysis | Tagged , , , , | 1 Comment

3 Reasons Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Stock Is A Buy After Trulance Approval

SGYP stock owners sold the Trulance FDA approval news, creating a good long-term opportunity in Synergy Pharmaceuticals. What about short-term?

Posted in Editor's Pick, Healthcare & Biotech, Members | Tagged , , , , , | 4 Comments